miRNA-221 and miRNA-222 are promising biomarkers for the progression of liver fibrosis in HCV Egyptian Patients.

Authors

Amanda Abdel-Al, The American University in Cairo (AUC)
Amgad Ouf, The American University in Cairo (AUC)
Suher Zada, The American University in Cairo (AUC)

Author's Department

Biology Department

Second Author's Department

Biology Department

Third Author's Department

Biology Department

Find in your Library

https://www.sciencedirect.com/science/article/pii/S0168170218302818?via%3Dihub

All Authors

Amanda Abdel-Al; Eman El-Ahwany; Mona Zoheiry; Marwa Hassan; Amged Ouf; Hoda Abu-Taleb; Ali Abdel Rahim; Mohamed Darwish El-Talkawy; Suher Zada

Document Type

Research Article

Publication Title

Virus Research

Publication Date

7-15-2018

doi

10.1016/j.virusres.2018.06.007

First Page

135

Last Page

139

Recommended Citation

APA Citation

Abdel-Al, A. Ouf, A. & Zada, S. (2018). miRNA-221 and miRNA-222 are promising biomarkers for the progression of liver fibrosis in HCV Egyptian Patients.. Virus Research, 253, 135–139. 10.1016/j.virusres.2018.06.007
https://fount.aucegypt.edu/faculty_journal_articles/5

MLA Citation

Abdel-Al, Amanda, et al. "miRNA-221 and miRNA-222 are promising biomarkers for the progression of liver fibrosis in HCV Egyptian Patients.." Virus Research, vol. 253, 2018, pp. 135–139.
https://fount.aucegypt.edu/faculty_journal_articles/5